Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argonaute 2 (AGO2) is the core catalytic component of the RNA-induced silencing complex (RISC), a multiprotein ribonucleoprotein complex responsible for post-transcriptional gene silencing via RNA interference (RNAi). Guided by small non-coding RNAs, such as microRNAs (miRNAs) or small interfering RNAs (siRNAs), AGO2 acts as an endonuclease (Slicer) that directly cleaves target messenger RNAs (mRNAs) with high complementarity, or represses translation when complementarity is partial. AGO2 is highly implicated in various human pathologies, particularly in oncology, where its overexpression promotes tumor growth, metastasis, and angiogenesis, and suppresses antitumor immunity. It also plays roles in viral infections, neurodegenerative diseases, and cardiovascular disorders. Therapeutic strategies targeting AGO2/RISC include small-molecule inhibitors (e.g., BCI-137, acriflavine, and aurintricarboxylic acid) that block miRNA loading or disrupt RISC assembly, as well as antisense oligonucleotides (e.g., miravirsen) that prevent miRNA-AGO2 interactions. Conversely, the AGO2/RISC machinery is also harnessed by therapeutic siRNAs to achieve targeted gene knockdown.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argonaute 2 / RNA-induced silencing complex (AGO2/RISC).